Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2022
Oct. 31, 2021
Current assets:    
Cash and cash equivalents $ 12,360 $ 29,128
Short–term investments 17,327 6,599
Prepaid expenses and other current assets 513 276
Total current assets 30,200 36,003
Operating lease right-of-use asset 212 254
Total assets 30,412 36,257
Current liabilities:    
Accounts payable 265 136
Accrued expenses 1,726 1,095
Operating lease liability 46 39
Total current liabilities 2,037 1,270
Operating lease liability, non-current 175 220
Total liabilities 2,212 1,490
Commitments and contingencies (Note 7)  
Shareholders’ equity:    
Preferred stock
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,913,902 and 30,050,894 shares issued and outstanding as of October 31, 2022 and 2021, respectively 309 301
Additional paid-in capital 247,123 239,927
Accumulated deficit (218,385) (204,790)
Total shareholders’ equity 29,047 35,438
Noncontrolling interest (Note 2) (847) (671)
Total equity 28,200 34,767
Total liabilities and equity 30,412 36,257
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock